sur Relief Therapeutics Holding SA (ETR:RLF)
MindMaze Therapeutics Shares AGM Results
MindMaze Therapeutics Holding SA, a prominent player in precision neurotherapeutics, disclosed the outcomes of its recent Annual General Meeting. Shareholders approved all Board proposals except for an increase in conditional share capital, which failed to secure the requisite majority.
Walid Hanna, Olaf Blanke, and Martin Reiss were re-elected to the Board. New appointments include Brad Hollinger and Zach Henderson. Additionally, the 2025 Annual Report and financial statements were ratified, along with earnings allocation and Board member discharges. Other approvals covered the Chairman's re-election, committee elections, and compensation agreements.
Further specifics on shareholder proposals are in the AGM Invitation, with detailed votes to be available on MindMaze's website today.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Relief Therapeutics Holding SA